Conceptio › Archive › HAL (France)
HAL (France)open access

CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure

Elodie Coquan et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
quality-of-life
Cabozantinib, Anti angiogenic treatment, 0, Metastatic cervical carcinoma, Quality of life
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 670149
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.